In this episode of Breast Cancer Insights, Harold Burstein, MD, PhD, speaks with Dana-Farber breast cancer experts Sara Tolaney, MD, MPH; Nancy Lin, MD; Erica Mayer, MD, MPH; and Jennifer Ligibel, MD, about important breast cancer research presented at the 2026 ASCO Annual Meeting.

The experts discuss new findings across breast cancer, including advances in treatment, clinical trial results, and research that may help shape the future of breast cancer care.

Chapters:
00:00:00 Intro
00:01:48 OPTIMA Trial Overview – Dr. Nancy Lin
00:11:37 SERENA-6 Results – Dr. Erica Mayer
00:21:20 VIKTORIA-1 Clinical Data – Dr. Erica Mayer
00:33:04 Destiny Breast09 Updates – Dr. Sara Tolaney
00:39:57 GLP-1 and Cancer Research – Dr. Jennifer Ligibel
00:51:00 Q&A Session
00:59:07 Outro

For more information about Dana-Farber’s Breast Oncology Center, visit https://www.dana-farber.org/cancer-care/treatment/breast-oncology

Follow us on social media:
Instagram: @danafarber_breast
Facebook: Dana-Farber Breast Oncology
X: @DFCI_BreastOnc

Disclaimer
This content is for informational and educational purposes only and is not intended as medical advice. Please consult a qualified healthcare professional for personalized medical guidance. The presented content reflects the views of the speakers and should not be interpreted as representing the views or policies of Dana-Farber Cancer Institute.